InMode Ltd. (NASDAQ:INMD) Short Interest Update

InMode Ltd. (NASDAQ:INMD - Get Free Report) was the target of a large growth in short interest in April. As of April 30th, there was short interest totalling 5,910,000 shares, a growth of 6.9% from the April 15th total of 5,530,000 shares. Based on an average daily volume of 1,580,000 shares, the days-to-cover ratio is currently 3.7 days.

Wall Street Analysts Forecast Growth

INMD has been the topic of several research reports. UBS Group raised their price objective on shares of InMode from $24.00 to $26.00 and gave the stock a "neutral" rating in a research report on Wednesday, February 14th. Barclays lowered their target price on shares of InMode from $34.00 to $33.00 and set an "overweight" rating on the stock in a report on Friday, April 12th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of InMode in a report on Friday, May 3rd. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $32.80.

Institutional Investors Weigh In On InMode

A number of institutional investors have recently bought and sold shares of INMD. Principal Securities Inc. purchased a new stake in InMode during the fourth quarter worth approximately $32,000. Headlands Technologies LLC grew its stake in InMode by 118.2% during the first quarter. Headlands Technologies LLC now owns 1,916 shares of the healthcare company's stock worth $41,000 after buying an additional 1,038 shares during the period. Sunbelt Securities Inc. acquired a new position in shares of InMode during the third quarter worth $47,000. Trust Co. of Vermont boosted its stake in shares of InMode by 32.8% in the fourth quarter. Trust Co. of Vermont now owns 2,168 shares of the healthcare company's stock valued at $48,000 after purchasing an additional 536 shares during the period. Finally, Newbridge Financial Services Group Inc. grew its holdings in InMode by 69.2% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 2,200 shares of the healthcare company's stock valued at $49,000 after purchasing an additional 900 shares in the last quarter. 68.04% of the stock is currently owned by hedge funds and other institutional investors.

InMode Stock Down 1.1 %

Shares of NASDAQ:INMD traded down $0.21 during trading on Thursday, reaching $18.64. The stock had a trading volume of 1,024,470 shares, compared to its average volume of 1,526,285. The business has a fifty day moving average price of $19.30 and a 200-day moving average price of $21.27. The stock has a market cap of $1.57 billion, a P/E ratio of 8.84 and a beta of 2.20. InMode has a fifty-two week low of $16.72 and a fifty-two week high of $48.25.

InMode (NASDAQ:INMD - Get Free Report) last posted its quarterly earnings data on Tuesday, February 13th. The healthcare company reported $0.71 earnings per share for the quarter, beating analysts' consensus estimates of $0.66 by $0.05. The business had revenue of $126.80 million during the quarter, compared to analyst estimates of $124.77 million. InMode had a net margin of 38.84% and a return on equity of 26.15%. The company's revenue was down 5.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.69 earnings per share. As a group, equities analysts forecast that InMode will post 1.8 EPS for the current year.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.